GLP-1 receptor agonist vs aspirin for primary prevention of colorectal cancer: Evidence from a real-world head-to-head comparison.
Colton Jones(The University of Texas at San Antonio), Sukeshi Patel Arora(The University of Texas MD Anderson Cancer Center), Danielle Lewis(Jefferson Hospital), Tarfa Verinumbe(Albert Einstein College of Medicine), Muluken Megiso(Jefferson Hospital), Elvis Obomanu(Jefferson Einstein Philadelphia Hospital), Akil Olliverrie(Brooklyn Hospital Center), Karecia Byfield(Jefferson Hospital), Ariana Neely(Jefferson Hospital), Damion Persad(Jefferson Hospital), Chidiebube Ugwu(Jefferson Einstein Philadelphia Hospital), Fnu Deepali(Unknown)
Cited by 3
Related Papers
The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer
|BMC Cancer|2015|19
Scale-up of antiretroviral treatment access among people living with HIV in Rivers State, Nigeria, 2019--2020
|AIDS|2021|16
Characterizing the Relationship between HIV Peer Support Groups and Internalized Stigma Among People Living with HIV in Nigeria
|AIDS and Behavior|2023|15
Second-line treatment with nivolumab, cabozantinib, regorafenib, or best supportive care in patients with advanced hepatocellular carcinoma: analysis at a Hispanic-majority NCI-designated cancer center
|Journal of Gastrointestinal Oncology|2021|5
Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD
|Drug and Alcohol Dependence Reports|2024|4